Prophylactic Left Atrial Appendage Exclusion in Cardiac Surgery Patients With Elevated CHA ₂ DS ₂ -VASc Score: Results of the Randomized ATLAS Trial

Abstract

ATLAS demonstrated a high rate of successful LAAE with low LAAE-related serious adverse events in cardiac surgery patients. Study results should be considered in future trial design to further evaluate prophylactic LAAE for stroke prevention in cardiac surgery patients with elevated stroke risk.